| UCB, S.A. Patent applications |
| Patent application number | Title | Published |
|---|
| 20110027359 | Novel Pharmaceutical Compositions Comprising Levetiracetam - The present invention relates to a pharmaceutical composition comprising levetiracetam as active ingredient, the invention relates specifically to a prolonged release formulation. | 02-03-2011 |
| 20100063105 | PHARMACEUTICAL USES AND SYNTHESIS OF NICOTINANILIDE-N-OXIDES - Disclosed are nicotinanilide-N-oxide compounds, methods for their production, pharmaceutical compositions which include these compounds, and methods for their use in various therapies. | 03-11-2010 |
| 20100003755 | Methods for identifying genomic deletions - The genomic locus responsible for Van Buchem's disease is narrowed to an approximately 92 kb region of human chromosome 17 at 17q21. Individuals afflicted with or carriers of Van Buchem's disease exhibit a 52 kb deletion within this 92 kb region. Methods are provided that permit the differentiation between individuals homozygous for and therefore afflicted with Van Buchem's disease, individuals heterozygous for and therefore carriers of Van Buchem's disease, and individuals who are normal with respect to Van Buchem's disease. Also provided are general methodologies for the detection of a wide variety of large genomic deletions. | 01-07-2010 |
| 20090169543 | Method for regulating immune function in primates using the Foxp3 protein - Isolated nucleic acid molecules are provided which encode Fkh | 07-02-2009 |
| 20090156607 | 2-OXO-1-PYRROLIDINE DERIVATIVES - The present invention concerns 2-oxo-1-pyrrolidine derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals. | 06-18-2009 |
| 20090087439 | Compositions and methods for diagnosing or treating psoriasis - In one aspect, the present invention provides isolated nucleic acid molecules that encode a CAN-1 polypeptide, or an STG polypeptide. In another aspect, the present invention also provides isolated STG polypeptides, isolated CAN-1 polypeptides, and isolated SEEK-1 polypeptides. In another aspect, the present invention provides isolated antibodies that bind specifically to a CAN-1, SEEK-1 or STG polypeptide. In another aspect, the present invention provides methods of diagnosing or predicting the susceptibility to psoriasis of an individual. In another aspect, the present invention provides methods for ameliorating the symptoms and/or progression of psoriasis. | 04-02-2009 |
| 20080299122 | Modulating immune responses - The invention provides methods for modulating the immune system using anti-CD83 antibodies that can influence CD83 function. | 12-04-2008 |
| 20080206331 | TABLET COMPRISING EFLETIRIZINE AND PSEUDOEPHEDRINE - The present invention concerns a tablet comprising two distinct segments. More particularly the invention relates to combinations of two pharmaceutical substances and methods of treatment of allergic disorders. | 08-28-2008 |
